Medtronic (MDT)
(Delayed Data from NYSE)
$79.74 USD
+0.49 (0.62%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $79.98 +0.24 (0.30%) 7:58 PM ET
4-Sell of 5 4
C Value D Growth A Momentum C VGM
Balance Sheet
Fiscal Year End for Medtronic PLC falls in the month of April.
All items in Millions except Per Share data.
4/30/2023 | 4/30/2022 | 4/30/2021 | 4/30/2020 | 4/30/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 7,959 | 10,573 | 10,817 | 10,948 | 9,848 |
Receivables | 5,998 | 5,551 | 5,462 | 4,645 | 6,222 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 5,293 | 4,616 | 4,313 | 4,229 | 3,753 |
Other Current Assets | 2,425 | 2,318 | 1,955 | 2,209 | 2,144 |
Total Current Assets | 21,675 | 23,059 | 22,548 | 22,031 | 21,967 |
Net Property & Equipment | 5,569 | 5,413 | 5,221 | 4,828 | 4,675 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 3,477 | 3,403 | 3,169 | 2,832 | 1,519 |
Intangibles | 56,269 | 56,097 | 59,701 | 58,904 | 60,519 |
Deposits & Other Assets | 3,959 | 3,008 | 2,443 | 2,094 | 1,014 |
Total Assets | 90,948 | 90,981 | 93,083 | 90,689 | 89,694 |
Liabilities & Shareholders Equity | 4/30/2023 | 4/30/2022 | 4/30/2021 | 4/30/2020 | 4/30/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 2,662 | 2,276 | 2,106 | 1,996 | 1,953 |
Current Portion Long-Term Debt | 20 | 3,742 | 11 | 2,776 | 838 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 5,530 | 5,672 | 5,957 | 5,092 | 5,114 |
Income Taxes Payable | 840 | 704 | 435 | 502 | 567 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 9,051 | 12,394 | 8,509 | 10,366 | 8,472 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 708 | 884 | 1,028 | 1,174 | 1,278 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 24,344 | 20,372 | 26,378 | 22,021 | 24,486 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 5,180 | 4,610 | 5,564 | 6,256 | 5,246 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 39,283 | 38,260 | 41,481 | 39,817 | 39,482 |
Shareholders Equity | 4/30/2023 | 4/30/2022 | 4/30/2021 | 4/30/2020 | 4/30/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 24,590 | 24,566 | 26,319 | 26,165 | 26,532 |
Retained Earnings | 30,392 | 30,250 | 28,594 | 28,132 | 26,270 |
Other Equity | -3,317 | -2,094 | -3,311 | -3,425 | -2,590 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 51,665 | 52,722 | 51,602 | 50,872 | 50,212 |
Total Liabilities & Shareholder's Equity | 90,948 | 90,981 | 93,083 | 90,689 | 89,694 |
Total Common Equity | 51,665 | 52,722 | 51,602 | 50,872 | 50,212 |
Shares Outstanding | 1,330.40 | 1,341.50 | 1,348.00 | 1,340.10 | 1,341.10 |
Book Value Per Share | 38.83 | 39.30 | 38.28 | 37.96 | 37.44 |
Fiscal Year End for Medtronic PLC falls in the month of April.
All items in Millions except Per Share data.
1/31/2024 | 10/31/2023 | 7/31/2023 | 4/30/2023 | 1/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 8,321 | 7,734 | 7,876 | 7,959 | 11,137 |
Receivables | 5,968 | 5,934 | 5,806 | 5,998 | 5,887 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 5,726 | 5,754 | 5,668 | 5,293 | 5,375 |
Other Current Assets | 2,499 | 2,658 | 2,518 | 2,425 | 2,965 |
Total Current Assets | 22,513 | 22,081 | 21,869 | 21,675 | 25,364 |
Net Property & Equipment | 5,838 | 5,735 | 5,665 | 5,569 | 5,437 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 3,599 | 3,428 | 3,461 | 3,477 | 3,361 |
Intangibles | 54,850 | 54,881 | 55,870 | 56,269 | 56,830 |
Deposits & Other Assets | 4,036 | 3,962 | 3,912 | 3,959 | 3,142 |
Total Assets | 90,836 | 90,087 | 90,776 | 90,948 | 94,134 |
Liabilities & Shareholders Equity | 1/31/2024 | 10/31/2023 | 7/31/2023 | 4/30/2023 | 1/31/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 1,992 | 2,174 | 2,239 | 2,662 | 2,209 |
Current Portion Long-Term Debt | 1,029 | 1,339 | 519 | 20 | 5,918 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 5,662 | 5,057 | 5,276 | 5,530 | 5,637 |
Income Taxes Payable | 1,109 | 1,088 | 1,013 | 840 | 657 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 9,793 | 9,659 | 9,047 | 9,051 | 14,422 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 615 | 686 | 687 | 708 | 747 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 24,153 | 23,741 | 24,463 | 24,344 | 22,210 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 4,280 | 5,214 | 5,180 | 5,138 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 38,840 | 38,440 | 39,410 | 39,283 | 42,516 |
Shareholders Equity | 1/31/2024 | 10/31/2023 | 7/31/2023 | 4/30/2023 | 1/31/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 24,589 | 24,580 | 24,587 | 24,590 | 24,513 |
Retained Earnings | 30,661 | 30,256 | 30,265 | 30,392 | 30,117 |
Other Equity | -3,255 | -3,190 | -3,486 | -3,317 | -3,012 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 51,996 | 51,647 | 51,366 | 51,665 | 51,618 |
Total Liabilities & Shareholder's Equity | 90,836 | 90,087 | 90,776 | 90,948 | 94,134 |
Total Common Equity | 51,996 | 51,647 | 51,366 | 51,665 | 51,618 |
Shares Outstanding | 1,327.80 | 1,329.60 | 1,330.50 | 1,330.40 | 1,330.40 |
Book Value Per Share | 39.16 | 38.84 | 38.61 | 38.83 | 38.80 |